France considers slowing vaccine rollout for hospital staff, with many unable to work following jab | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

France considers slowing vaccine rollout for hospital staff, with many unable to work following jab

The AstraZeneca experimental COVID-19 vaccine currently being given to health workers in France has caused so many side-effects that the French vaccination task force (Conseil d’orientation de la stratégie vaccinale) has recommended “a staggering of the vaccination schedule for people working in the same care unit” as well as “the systematic intake of paracetamol just before the injection and in the two following days.”

The vaccine was developed by Oxford University together with the British-Swedish pharmaceutical company AstraZeneca by cultivating the weakened SARS-CoV-2 virus in the HEK-293 cell line derived from the kidney of an aborted baby. According to the Oxford Vaccine Centre, these weakened viruses “are purified several times to remove the cell culture material,” adding that “this makes it unlikely that any human material remains in the final vaccine.” “Unlikely”, it is worth noting, does not mean “impossible.”

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA